The laboratory anomalies of the patients were hyponatremia in 80/281 (28.5%), hyperkalemia in 9/226 (4%), hypokalemia in 25/226 (11.1%), hypocalcemia in 20/136 (14.7%), hyperphosphatemia in 22/135 (16.3%), hyperuricemia in 20/108 (18.5%), increased ALT in 60/189 (31.7%), increased AST in 79/193 (40.9%), increased LDH in 62/109 (56.9%), increased CRP in 145/273 (53.1%), hypoalbuminemia in 26/95 (27.4%), and metabolic acidosis in 16/99 (16.2%) patients. This evidence concerns the gene GPT and metabolic process.